Engaged in diverse basic, translational and clinical research, our faculty routinely publish in prestigious journals and successfully compete for major grants from national funders.
Phuong HT, Tomas RF, Akmese C, Mijares A, Gerstin IM, Guo S, Bell LR, Ellwood R, Yegorova S, Ng SK, Massey G, Phillips J, Melloni A, Pletnikova O, Lou X, Clark HB, Troncoso JC, Hyman BT, Prokop S, Ranum LPW, Nguyen L. (2025) PolyGR-containing aggregates link with pathology and clinical features of Alzheimer's disease. Acta Neuropathologica (Nov), 150 doi:10.1007/s00401-025-02954-8
A phase 3 double-blind study to evaluate the efficacy and safety of oral ozanimod compared to oral fingolimod in children and adolescents with relapsing-remitting multiple sclerosis. Michael Dwyer, III (Co-Investigator). Bristol Myers Squibb. $1,649,376. 6/1/2023-12/1/2032.
CTSA State University of New York at Buffalo. Zackary Falls (Contributor). National Center for Advancing Translational Sciences (NCATS). $29,204,726. 1/1/2025-12/1/2031.
Clinical and Translational Science Award. Core Operations Special Populations. Ralph Benedict (Co-Investigator). NIH. $29,204,726. 1/1/2025-12/1/2031.
CTSA UM1 State University of New York at Buffalo. Praveen Chandrasekharan (Principal Investigator). NIH/NCATS. 8/1/2025-7/1/2031.
The UB Primary Care Training and Enhancement – Residency Training in Street Medicine. Brian Clemency (Co-Investigator). HRSA. $2,500,000. 9/1/2025-9/1/2030.
Structure and assembly of membrane proteins at tight junctions. Alex Vecchio (Principal Investigator). NIH/NIGMS. $2,166,105. 9/1/2025-8/1/2030.
Revolutionizing Protein Structure Determination with Advanced SWAXS Analysis. Thomas Grant (Principal Investigator). NIH NIGMS. $2,181,805. 8/1/2025-7/1/2030.
Prevention of Postpartum Smoking Relapse and Related Health Consequences by Breastfeeding Promotion. Xiaozhong Wen (Principal Investigator). National Institute of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development. $3,361,314. 8/1/2025-7/1/2030.
CTSA K12 Program State University of New York at Buffalo. Praveen Chandrasekharan (Principal Investigator). NIH/NCATS. 6/1/2025-7/1/2030.
Interplay between limbic norepinephrine and dopamine circuits in sex differences in reward and aversion. Jinwoo Park (Principal Investigator). NIH/NIDA. $3,739,074. 8/1/2025-4/1/2030.
Role of Intrinsic Neuroprotective Signaling in Diabetic Retina. Sarah Zhang (Principal Investigator). National Eye Institute, NIH. $2,587,505. 4/1/2025-3/1/2030.
Selective galactosylceramidase ablation to study the pathogenesis of Krabbe leukodystrophy. Pablo Paez (Co-Investigator). National Institute of Neurological Disorders and Stroke (NINDS). $1,950,000. 2/1/2025-1/1/2030.